J.P. Morgan Healthcare Conference January 9, 2023 Forward - Looking Statements Statements contained in this presentation regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Examples of these forward-looking statements include statements concerning the Company's ability to successfully commercialize KORSUVA injection and Kapruvia, future revenue and profit share from sales of KORSUVA and Kapruvia, planned ...

Cara Therapeutics, Inc. (NASDAQ:CARA) Q3 2022 Earnings Conference Call November 7, 2022 4:30 PM ET Company Participants Matthew Murphy - Manager, Investor Relations Christopher Posner - President, CEO & Director Ryan Maynard - CFO Joana Goncalves - Chief Medical Officer Conference Call Participants Sumant Kulkarni - Canaccord Genuity Joseph Stringer - Needham & Company Daniel Wolle - JPMorgan Chase & Co. Chi Meng Fong - Bank of America Merrill Lynch Stacy Lee - Stifel David Amsellem - Piper Sandler & Co. Op ...

Cara Therapeutics, Inc. (NASDAQ:CARA) Q2 2022 Results Conference Call August 8, 2022 4:30 PM ET Company Participants Iris Francesconi - Head of Investor Relations Christopher Posner - President and Chief Executive Officer Richard Makara - Interim Chief Financial Officer Joana Goncalves - Chief Medical Officer Conference Call Participants Daniel Wolle - JPMorgan Christopher Howerton - Jefferies Joseph Stringer - Needham & Company David Amsellem - Piper Sandler Oren Livnat - H.C. Wainwright Jason Gerberry - B ...

Cara Therapeutics, Inc. (NASDAQ:CARA) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Iris Francesconi - Interim Head, Investor Relations Chris Posner - President & Chief Executive Officer Tom Reilly - Chief Financial Officer Joana Goncalves - Chief Medical Officer. Conference Call Participants Joseph Stringer - Needham & Company Chi Tran - Bank of America Daniel Wolle - JPMorgan David Amsellem - Piper Sandler Sumant Kulkarni - Canaccord Oren Livnat - H.C. Wainwright Operator G ...

Welcome to Cara Therapeutics 2022 R&D Day MARCH 11, 2022 Forward Looking Statements Statements contained in this presentation regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Examples of these forwardlooking statements include statements concerning the expected timing of the initiation, enrollment and data readouts from the Company's planned and ongoing clinical trials, the potential results of ongoin ...

Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2021 Earnings Conference Call March 1, 2022 4:30 PM ET Company Participants Iris Francesconi - Interim Head, Investor Relations Christopher Posner - President, CEO & Director Thomas Reilly - CFO Joana Goncalves - Chief Medical Officer Conference Call Participants Joseph Stringer - Needham & Company Nicholas Rubino - Stifel, Nicolaus & Company Sumant Kulkarni - Canaccord Genuity Chi Zhang - Bank of America Merrill Lynch Daniel Wolle - JPMorgan Chase & Co. David Amsell ...

Cara Therapeutics, Inc. (NASDAQ:CARA) Q3 2021 Earnings Conference Call November 8, 2021 4:30 PM ET Company Participants William Gramig - Stern Investor Relations Derek Chalmers - President and Chief Executive Officer Christopher Posner - Incoming CEO Thomas Reilly - Chief Financial Officer Conference Call Participants Jessica Fye - JPMorgan Chris Howerton - Jefferies David Amsellem - Piper Sandler Annabel Samimy - Stifel Operator Good afternoon and welcome to Cara Therapeutics’ Third Quarter 2021 Financial ...

Cara Therapeutics, Inc. (NASDAQ:CARA) Q2 2021 Earnings Conference Call August 9, 2021 4:30 PM ET Company Participants Cole Herlitz-Ferguson - Stern Investor Relations Derek Chalmers - President and Chief Executive Officer Thomas Reilly - Chief Financial Officer Conference Call Participants Jessica Fye - J.P. Morgan Chris Howerton - Jefferies David Amsellem - Piper Sandler Jason Gerberry - Bank of America Jack Padovano - Stifel Oren Livnat - H.C. Wainwright Operator Good afternoon and welcome to the Cara The ...

Targeting Pruritus with First-In-Class Therapeutics MAY 10, 2021 Forward Looking Statements Statements contained in this presentation regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Examples of these forwardlooking statements include statements concerning the expected timing of the enrollment and data readouts from the Company's ongoing clinical trials, the potential results of ongoing clinical trial ...

Call Start: 16:30 January 1, 0000 5:11 PM ET Cara Therapeutics, Inc. (NASDAQ:CARA) Q1 2021 Earnings Conference Call May 10, 2021 16:30 ET Company Participants Jack Hildick-Smith - Investor Relations Derek Chalmers - Chief Executive Officer Thomas Reilly - Chief Financial Officer Conference Call Participants Chris Howerton - Jefferies David Amsellem - Piper Sandler Joseph Stringer - Needham & Company Oren Livnat - H.C. Wainwright Operator Good afternoon and welcome to Cara Therapeutics First Quarter 2021 Fin ...